In this case, the pill, called VXA-G1.1-NN, has been designed to deliver a harmless viral vector carrying a norovirus protein directly to the small intestine. This is not the only norovirus vaccine ...

Viral-vectored vaccines can be designed quickly. One concern is that people can develop immunity to the viral vector, making this approach potentially less useful if booster shots need to be given.

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract allows for robust antibody and T-cell responses where SARS-CoV-2 generally ...

Full-year results and business updateClinical proof of principle obtained in Phase I adjuvant head and neck cancer trial with individualized ...

Researchers from the J. Craig Venter Institute (JCVI), the Friedrich-Loeffler-Institut (FLI), and the International Livestock ...

AAP FactCheck - A study of the immune patterns in vaccinated people does not show mRNA jabs are giving people AIDS, despite ...

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 24.03.2025 / 13:05 CET/CEST The issuer is ...

Infrastructure and Viral Vector Production Facility at Genome Valley in Telangana's Hyderabad expanding its expertise from ...

Here is everything you need to know about the recent case of human coronavirus case in Kolkata. Understanding the symptoms of ...

Apriori Bio has become the latest Flagship Pioneering-backed biotech to shed staff, cutting 15 workers to leave 21 still ...

Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...